Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Doc Ophthalmol ; 129(1): 17-26, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24817488

ABSTRACT

BACKGROUND: The aim of this study was to develop a fast and efficient electrophysiological protocol to examine the visual field's integrity, which would be useful in pediatric testing. METHODS: Steady-state visual-evoked potentials (ssVEPs) to field-specific radial checkerboards flickering at two cycle frequencies (7.5 and 6 Hz for central and peripheral stimulations, respectively) recorded at Oz were collected from 22 participants from 5 to 34 years old and from 5 visually impaired adolescents (12-16 years old). Responses from additional leads (POz, O1, O2), and the impact of gaze deviation on the signals, were also investigated in a subgroup of participants. RESULTS: Steady-state visual-evoked potentials responses were similar at all electrode sites, although the signal from the central stimulation was significantly higher at Oz and was highly sensitive in detecting gaze deviation. No effect of age or sex was found, indicating similar ssVEP responses between adults and healthy children. Visual acuity was related to the central signal when comparing healthy participants with four central visual impaired adolescents. Clinical validation of our electrophysiological protocol was also achieved in a 15-year-old adolescent with a severe peripheral visual deficit, as assessed with Goldmann perimetry. CONCLUSIONS: A single electrode over Oz is sufficient to gather both central and peripheral visual signals and also to control for gaze deviation. Our method presents several advantages in evaluating visual fields integrity, as it is fast, reliable, and efficient, and applicable in children as young as 5 years old. However, a larger sample of healthy children should be tested to establish clinical norms.


Subject(s)
Electrophysiology/methods , Evoked Potentials, Visual/physiology , Vision Disorders/diagnosis , Visual Fields/physiology , Adolescent , Adult , Child , Child, Preschool , Electroencephalography , Female , Humans , Male , Photic Stimulation , Vision Disorders/physiopathology , Visual Acuity/physiology , Visual Field Tests
2.
Pediatr Neurol ; 59: 47-53, 2016 06.
Article in English | MEDLINE | ID: mdl-27105764

ABSTRACT

BACKGROUND: We assessed central and peripheral visual field processing in children with epilepsy who were exposed to vigabatrin during infancy. METHODS: Steady-state visual evoked potentials and pattern electroretinograms to field-specific radial checkerboards flickering at two cycle frequencies (7.5 and 6 Hz for central and peripheral stimulations, respectively) were recorded from Oz and at the eye in seven school-age children (10.1 ± 3.5 years) exposed to vigabatrin early in life, compared with children early exposed to other antiepileptic drugs (n = 9) and healthy children (n = 8). The stimulation was made of two concentric circles (0 to 5 and 30 to 60 degrees of angle) and presented at four contrast levels (96%, 64%, 32%, and 16%). RESULTS: Ocular responses were similar in all groups for central but not for the peripheral stimulations, which were significantly lower in the vigabatrin-exposed group at high contrast level. This peripheral retinal response was negatively correlated to vigabatrin exposure duration. Cortical responses to central stimulations, including contrast response functions in the children with epilepsy in both groups, were lower than those in normally developing children. CONCLUSIONS: Alteration of ocular processing was found only in the vigabatrin-exposed children. Central cortical processing, however, was impaired in both epileptic groups, with more pronounced effects in vigabatrin-exposed children. Our study suggests that asymptomatic long-term visual toxicity may still be present at school age, even several years after discontinuation of drug therapy.


Subject(s)
Anticonvulsants/adverse effects , Vigabatrin/adverse effects , Vision Disorders/chemically induced , Vision Disorders/physiopathology , Visual Fields/drug effects , Visual Fields/physiology , Adolescent , Anticonvulsants/therapeutic use , Child , Child, Preschool , Electroencephalography , Electroretinography , Evoked Potentials, Visual/drug effects , Female , Humans , Male , Retina/drug effects , Retina/growth & development , Retina/physiopathology , Vigabatrin/therapeutic use , Vision, Ocular/drug effects , Vision, Ocular/physiology , Visual Cortex/drug effects , Visual Cortex/growth & development , Visual Cortex/physiopathology , Visual Perception/drug effects , Visual Perception/physiology
SELECTION OF CITATIONS
SEARCH DETAIL